House Rx to Launch Specialty Drug Dispensing Inside Rheumatology Clinics By Partnering with Three Leading Practices
Retrieved on:
Wednesday, August 3, 2022
CFO, Physician, Quality of life, Australian Rheumatology Association, SAN, DO, Patient, Consultant, Rheumatology, Multimedia, Health, Private practice, Pharmacy, Adult, Technology, Research, AOCC, House, Pharmacy benefit management, Entrepreneurship, Pharmacy technician, Arthritis, Nursing, CEO, Caregiver, Pharmacist, Partnership, MID, Population, Pharmaceutical industry, Medicine
SAN FRANCISCO, Aug. 3, 2022 /PRNewswire/ --House Rx, the platform for medically integrated dispensing of specialty medications, announced today it has partnered with three new rheumatology clinics to integrate in-house specialty drug dispensing also known as medically integrated dispensing (MID) into the clinics' operations.
Key Points:
- SAN FRANCISCO, Aug. 3, 2022 /PRNewswire/ --House Rx, the platform for medically integrated dispensing of specialty medications, announced today it has partnered with three new rheumatology clinics to integrate in-house specialty drug dispensing also known as medically integrated dispensing (MID) into the clinics' operations.
- While MID has grown in oncology, House Rx's partnership with these practices is one of the first to bring the model to rheumatology care.
- "It's very exciting to partner with key thought leaders in rheumatology to bring medically integrated dispensing to this specialty," said Ogi Kavazovic, Co-Founder and CEO of House Rx.
- By bringing specialty dispensing into the physician's office, the partnership with House Rx aims to dramatically improve the specialty medication experience for patients.